-
MorphoSys AG is a
German biopharmaceutical company founded in 1992. The
company is
headquartered near Munich, Germany, and has a
wholly owned subsidiary...
- for the
global development and
commercialization of
tafasitamab with
MorphoSys. On
March 3, 2020, the
agreement received antitrust clearance and thus...
- More Than $10 Billion". WSJ.
Retrieved 2023-12-01. AG,
MorphoSys (26
January 2016). "
MorphoSys Announces Clinical Milestone for
Start of Bayer's Phase...
-
human antibody which has been
developed by the
biotechnology company MorphoSys. It can also be
referred to as
HuCAL antibody,
HuCAL standing for Human...
-
Energiekontor Evotec Freenet Hensoldt Infineon Technologies Jenoptik Kontron MorphoSys Nagarro SE
Nemetschek Nordex PNE AG
Qiagen SAP
Sartorius Siemens Healthineers...
- Texas-Austin
MorphoSys: an
integrated reconfigurable system for data-parallel and com****tion-intensive
applications Design and
implementation of the
MorphoSys reconfigurable...
-
Proposed INN: List 117" (PDF). WHO Drug Information. 31 (2). "Ianalumab -
MorphoSys/Novartis". AdisInsight.
Springer Nature Switzerland AG. van den Hoogen...
- variation. In
January 2013, Bio-Rad
purchased AbD Serotec, a
division of
MorphoSys AG. This
added Serotec’s more than 15,000 antibodies, kits, and accessories...
-
February 2024,
Novartis announced it
would acquire the
German biotech firm
MorphoSys AG for €2.7bn.
Novartis Acquisitions Novartis Novartis (Merger of Ciba-Geigy...
- (since 2017)
Lonza Group,
Member of the
Board of
Directors (2012-2013)
MorphoSys,
Member of the
Supervisory Board (2001-2004)
Temasek Holdings, Member...